**Question:** Type II hypersensitivity

**Core Concept:** Type II hypersensitivity is a type of immune response where antibodies (IgE and IgG) bind to antigens on the surface of target cells, leading to activation and subsequent release of inflammatory mediators that cause tissue damage and clinical manifestations.

**Why the Correct Answer is Right:** Type II hypersensitivity is also known as immediate hypersensitivity or mediated by antibodies. It is triggered by the binding of specific antibodies (IgE and IgG) to antigens on the surface of target cells. In the case of IgE, it binds to mast cells and basophils, while IgG binds to macrophages, neutrophils, and other cells. This binding results in the activation of the target cells, leading to the release of inflammatory mediators such as histamine, proteases, and leukotrienes, which cause tissue damage and clinical manifestations. These mediators contribute to bronchoconstriction, vasodilation, increased vascular permeability, and recruitment of other immune cells, leading to symptoms like urticaria, angioedema, and anaphylaxis.

**Why Each Wrong Option is Incorrect:**

A. This option is incorrect because it does not describe the specific mechanism of Type II hypersensitivity involving antibody binding and inflammatory mediator release.

B. This option is incorrect as it does not address the specific role of antibodies (IgE and IgG) in Type II hypersensitivity and the subsequent inflammatory response.

C. This option is incorrect because it does not focus on the key mechanism of antibody binding to target cells and subsequent inflammatory mediator release, which is the essence of Type II hypersensitivity.

D. This option is incorrect as it does not specifically mention the role of antibodies (IgE and IgG) in triggering the inflammatory cascade and the clinical manifestations resulting from Type II hypersensitivity.

**Clinical Pearl:**

Type II hypersensitivity reactions can be life-threatening and should be recognized and managed promptly. Prompt diagnosis and treatment involve the use of antihistamines, corticosteroids, and epinephrine in severe cases. It is crucial to differentiate Type II hypersensitivity from other conditions like allergic urticaria, which is also characterized by skin rash and edema but lacks the involvement of antibodies and the subsequent inflammatory cascade seen in Type II hypersensitivity.